Bridging AI experimentation and real manufacturing outcomes by enabling production-ready, compliant systems that improve batch consistency and decision-making.
About the Webinar
Biologics manufacturing operates in a high-variability, highly regulated environment where small shifts can impact yield, quality, and timelines. While AI investments are widespread, consistent production impact remains limited. This session explores what it takes to move beyond pilots—making AI reliable, traceable, and actionable in real manufacturing environments—supported by a live example from a GxP-regulated workflow.
Core Challenges
AI not translating into consistent production outcomes
Fragmented process, batch, and material context
Insights not embedded into operational decisions
GxP constraints limiting deployment
High sensitivity to process variability
Key Takeaways
Move beyond pilots : Understand what enables real production impact
Make insights actionable: Translate outputs into decisions—not dashboards
Build GxP-ready AI : Ensure traceability, validation, and auditability
Improve consistency : Reduce variability-driven disruptions at scale
Demo 1: AI-Assisted Regulatory Review
AI-powered review of SOPs, deviations, and quality records against FDA & ICH frameworks
Citation-backed findings, remediation guidance, and AI-assisted audit response drafting
Deterministic, human-reviewed workflows with QMS integration and risk assessment support
Demo 2: Agentic AI for Intelligent Batch Yield Optimization
AI agents to monitor critical process parameters in real time to predict batch yield and quality outcomes
Early identification of process variability risks with AI recommendations for optimal operating conditions
Improve yield, process robustness, and scale-up consistency through AI-driven manufacturing insights